Search
APJ Virtual Genetic Solutions Tour 2020: Speakers
 Srinivas Chadaram, PhD
Dr. Srinivas Chadaram joined Thermo Fisher Scientific, in 2018, as a Sr. Product Manager, Agrigenomics, in the AgriBusiness Vertical. In this role, he is responsible for the portfolio of products supporting Agrigenomics vertical - including AgriSeq GBS and CE and working with the qPCR and microarrays teams supporting Agrigenomics solutions. Srinivas is based in the Austin, TX. Srinivas brings extensive experience to Thermo Fisher Scientific, with a strong healthcare and life Sciences background. He has been involved in several startups primarily helping in new product & solution development, starting from requirements gathering to commercialization of products. As a product manager at Advanced Liquid Logic, he successfully commercialized and launched Digital Micro fluidics based platform for screening and diagnosis of Rare Diseases and sample-prep platform for next generation sequencing, subsequently acquired by Illumina, Inc.. He also co-founded Aura Life, a natural product healthcare startup; and was in Business Development at MAXIMUS Federal. Srinivas is a graduate of Duke University, Fuqua School of Business with a MBA Degree, PhD in Zoology and Neurobiology from the University of Idaho and DVM from Acharya NG Ranga Agricultural University, College of Veterinary Science, Hyderabad, India. He has published several peer reviewed scientific papers. |
 Rommel Herrera, DVM
Veterinarian by profession Present position: Supervising Science Research Specialist at the Philippine Carabao Center at the University of the Philippines-Los Banos (UPLB), Laguna, Philippines Presently taking his PhD at the University of New England, NSW, Australia. Topic is on the use of genomic data on a dairy buffalo breeding program. |
 Arjun Kandalam, PhD
Dr. Arjun Kandalam is currently a Business Development Manager for Agrigenomics responsible for the Asia Pacific Japan region in Thermo Fisher Scientific. Arjun is a PhD in Molecular Oncology and comes with several years of expertise on Axiom microarrays. He also possesses experience in applying NGS technologies to solve problems in both human and agriculture biotechnology. Arjun has worked for Illumina and Affymetrix in the past and has been part of Thermo Fisher Scientific since it acquired Affymetrix in 2016. To Arjun's credit, he has 26 International peer- reviewed research publications in molecular oncology and was a gold medal winning PhD scholar. He was recognized as a best employee, twice by Illumina, for his expertise in offering superior technical support to researchers and for his business development performance in 2012 and 2013 He has also been recognized as Best Business Development employee for genotyping by Affymetrix in 2015. |
 Seokhyun Lee, PhD
Education (Degree, Major, Name of Organization or University in sequence of the latest year) 2019 - PhD, Department of Dairy Science, Chungnam National University, Korea 2016 - MSci, Department of Dairy Science, Chungnam National University, Korea Work Experience 2019 ~ Now - Researcher, Dairy Cattle Genetic Improvement Center, NACF Agribusiness Group 2016 ~ 2019 - Researcher, Animal Breeding & Genetics Division, National Institute of Animal Science, RDA 2012 ~ 2016 - Researcher, Department of Dairy Science, Chungnam National University, Korea Summary: SeokHyun Lee holds a PhD in statistical genetics. SeokHyun worked at National Institute of Animal Science, and conducted dairy cattle improvement work and research. Seokhyun joined Nonghyup in 2019 to improve dairy cattle. Interests: Animal Breeding, Genetics of Complex Traits, Genomic Selection, Population Genetics, Statistical genetics, Dairy Cattle. |
 Ryoma Takeshima, PhD
I obtained my Ph.D. from the Hokkaido University in Japan and joined the Institute of Crop Science, NARO of Japan in 2017. My interests are in the research area focused on the genetic mechanism of agronomical trait and a unique mating system of common buckwheat (Fagopyrum esculentum). I also attempt to breed new cultivars to improve the quality/quantity of products in buckwheat. |
 Kamlesh Jangid, PhD
Dr. Kamlesh Jangid completed his education in Microbiology from SP Pune University and did his Post-doctoral work at The University of Georgia, USA. His group at NCMR studies Microbial Ecology and Systematics, Bioinformatics and Soil Science. He is the Associate Chief Editor for Soil Biology and Biochemistry, Academic Editor for PLOS ONE and Frontiers in Microbiology. He is the President-elect of the Bergey's International Society for Microbial Systematics and an Academic Advisor to the China Agricultural University, Beijing. He has authored some of the most cited articles in Soil Science and has over 50 publications and successful research grants from US-NSF. Dr. Jangid represented India at the Global Soil Biodiversity Conference in China. During his postdoctoral work, he attended the prestigious Kadner Institute organized by the American Society of Microbiologists. Dr. Jangid is a very proactive and approachable researcher deeply committed to community science outreach. His team has developed SP Pune University's first Microbial Ecology Course as a Ph.D. pre-requisite. He actively teaches at various schools, colleges, universities. Through these activities, Dr. Kamlesh Jangid is motivating today's technologically advanced young generation toward scientific research. |
 Keun-Joon Park, PhD
Education ~ 2003.09, Kyoto University / PhD / Bioinformatics Employment History ~ Present, Thermo Fisher Scientific / Seoul, Korea / LPS (Lead Product Specialist). ~ 2010.09, National Institute of Health, Korea CDC / Seoul, Korea / Principal Researcher. ~ 2006.03, Human Genome Center, The University of Tokyo / Tokyo, Japan / Researcher. ~ 2005.03, Computational Biology Research Center / Tokyo, Japan / AIST Research Staff. |
 Steve Jackson, PhD
Dr. Jackson has over 10 years of experience in genetic analysis technologies. As a senior member of the Content Engine R&D team at Thermo Fisher Scientific, he helps develop solutions for the research and healthcare markets, leveraging varied technologies such as capillary electrophoresis, digital PCR, next-generation sequencing, and microarray analysis. Before Thermo Fisher Scientific, he was at Nanostring Technologies running the Field Applications Specialist (FAS) team. He was also an Acting Assistant Professor at University of Washington, Department of Genome Sciences, investigating developmental genetics of Drosophila melanogaster. |
 Harita Veereshlingam, PhD
Harita Veereshlingam is a Senior Product Application Scientist in the Genetic Sciences Division at Thermo Fisher Scientific. She has over 10 years of experience in product development with an emphasis on real time PCR assays for gene expression and miRNA analysis. In her current role, Harita is responsible for product portfolio growth through the development of novel applications, customer collaborations, technical notes, and webinars. She lives by and is a strong proponent of sustainable living. She has a PhD in Molecular Biology from the University of North Texas. |
 Emily Zeringer, PhD
Emily has worked as part of R&D at the Austin site for over 15 years. During her tenure, she has lead and contributed to multiple projects including sample preparation and analysis of nucleic acids (including real-time PCR) from a wide range of sample types, library preparation for sequencing, and purification and analysis of exosomes. Recently and for the past several years, her efforts have shifted to the development of high-throughput and automated DNA/RNA extraction methods from clinical samples (such as biofluids) for use within larger analysis workflows ranging from such as Pharmacogenomics, Pathogen/Microbial Detection, Disease studies and Biomarker studies. |
 Ashwin Dalal, MD
Dr. Ashwin Dalal is a recipient of Gold Medal in his MBBS exams. He did his post-graduation (MD) in Pediatrics from Goa Medical College, Goa University, followed by Super specialization (DM) in Medical Genetics from Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow. He is currently working with Centre for DNA Fingerprinting and Diagnostics, Hyderabad as Staff Scientist and Head of Diagnostics division. The genetic Diagnostic laboratory led by him at CDFD offers comprehensive diagnosis, genetic counselling and prenatal diagnosis of genetic diseases. He was instrumental in establishment of department of Medical Genetics at Nizam's Institute of Medical Sciences (NIMS), Punjagutta, Hyderabad. He is also Adjunct Visiting Professor in the Department of Medical Genetics Kasturba Medical College, Manipal, India. He is founding member and past secretary of Society for Indian Academy of Medical Genetics. He has published more than 100 papers in National and International journals. His research interests include identification of novel genes for single gene disorders and molecular analysis of genetic diseases. He has contributed chapters in textbooks for MBBS and MD (Pediatrics) students. He is also interested in teaching Medical Genetics and has conducted lectures in medical colleges and national conferences. He has been a member of various Task Forces of Department of Biotechnology, Indian Council of Medical Research and Department of Science and Technology, Government of India. |
 Ritu Hari, PhD
Completed MSc human genetics, PhD reproduction genetics from United Kingdom. Board of Genetic Counselling India (BGCI) certified Genetic counsellor. Have previously worked in UK in the field of reproductive genetics. Came back to India and took the biggest challenge to start a full-fledged Medical genetics laboratory in India. Joined CRAFT Hospital in 2013 as Chief Medical Geneticist and established heads the PGD laboratory and takes in charge of all the high-end genetic testing based on NGS. A hospital first In Asia pacific to have the ion torrent S5 XL. Has the credibility of performing first time in INDIA PGD on a tay sach carrier couple and thereby reporting INDIA'S first live birth on a rare mutation for tay sachs. India's first and world's second achondroplasia free baby born after PGD. Successful first-time attempt in India for a delivery of SMN free baby using NGS technology. Have also reported many successful cases of PGD/PGS for chromosomal translocations. Invited as a faculty in many national conferences. Recently felicitated as champion of ISAR year 2020. Has published many chapters and articles in reputed journals and books. Was a part of PGD consensus to frame guidelines for the country as an initiative from ISAR. |
 Youngjoo Jeon, PhD
Affiliation 2019 Jun ~ Present Division of Product Development, Theragen Genomecare, Korea (CSO, Chief Strategic Officer) 2015 May ~ 2019 May R&D Management Team, GC Genome (Green Cross Genome), Korea (Team Leader) 2014 Feb ~ 2015 Feb Clinical Research Team, TheragenEtex Bio Institute, Korea (Team Leader) 2010 Feb ~ 2014 Jan Institute for Clinical Research, CHA Bundang Medical Center, Korea (Research Associate) Education 2004 Mar ~ 2008 Feb Department of Life Science, University of Seoul, BS 2008 Mar ~ 2010 Feb Department of Life Science, University of Seoul, MS 2010 Mar ~ 2014 Feb Department of Biomedical Science, CHA University, PhD Awards 2013 Dec ~ SongAm Scientific Award, Korean Society of Hemostasis and Thrombosis 2016 Nov ~ Young Scientist Award, The Genetics Society of Korea |
 Mohamed Saleem, PhD
Dr. Saleem received his PhD in Medical Genetics from the University Putra Malaysia in 2011. From 2013-2016, Dr. Saleem did a postdoctoral fellowship at the University Sains Malaysia working on Acute Myeloid Leukaemia and Pharmacogenomics. Since 2016 he joined Advanced Genomics (GenomixLAB®) in Malaysia as the Laboratory Director. GenomixLAB® is a private molecular diagnostic service provider working especially in the domains of reproductive genetics and cancer genetics mostly using ION Chef and S5 workflows. Dr. Saleem has been working in in the filed of Genetics diagnostics since 2011. |
 Anuradha Udumudi, PhD
- PhD in Human Genetics - 25 years experience in medical genetics - Post-doctoral work in USA at UMDNJ Medical school (New Jersey), Walksman Institute (New Jersey), Integrated Lab Systems (North Carolina) - Worked at Laboratory Corporation of America's Medical Genetics division - Young Scientist Award (Environmental Mutagen Society, USA), other international awards - Published papers in several reputed international journals, and authored several book chapters - Over 350 CME lectures delivered at national and state level conferences (& 200 awareness camps) - Designed and developed many novel genetics diagnostic tests and panels, standardized more than 300 molecular diagnostic tests - Designed world's first and most comprehensive reproductive genomics panels, presented at ACMG 2019 - Seattle (USA) |
 Soren Alexandersen, PhD
Soren Alexandersen is a Veterinary Pathologist, Virologist and Epidemiologist specialising in molecular pathogenesis, epidemiology, detection and control of virus infections since 1982. He has worked in Denmark, USA, England and Canada and since October 2015 in Australia as a Professor and Director of the Geelong Centre for Emerging Infectious Diseases (GCEID), a One Health collaborative Centre including Deakin University, Barwon Health/University Hospital Geelong and the CSIRO Australian Animal Health Laboratory. |
 Rachel Formosa, PhD
Rachel Formosa is the senior director of global market development for the Genetic Sciences Division of Thermo Fisher Scientific. Her focus is on solutions that span real-time PCR, microarray and sequencing technologies. Rachel has developed expertise in these technologies over her 20+ years of experience with genetic analysis technologies, including the past ten years with Applied Biosystems products at Thermo Fisher Scientific. |
 Anjali Shah, PhD
- 14 years at the company in Product Marketing functions - B.S Honors Biology and B.A. Spanish from University of Illinois, Urbana-Champaign - Ph.D. Genetics and Development, Columbia University, New York, NY - Postdoctoral fellow, Howard Hughes Medical Institute, University of California, San Francisco |
 Timothy Triche, MD, PhD
Dr. Timothy Triche is the Co-Director for the Children's Hospital Los Angeles (CHLA) Center for Personalized Medicine. He previously served as Chief of the CHLA Department of Pathology and Laboratory Medicine for over 20 years. Prior to joining CHLA, Dr. Triche was Head of Molecular Diagnostics in the Laboratory of Pathology at the National Cancer Institute. At CHLA, he directs a cancer genomics, biology, and nanotechnology laboratory research program. He has developed numerous biomarker profiles for cancer diagnosis, prognosis and treatment as part of the NCI's Director's Challenge, SPECS and TARGET initiatives. His focus is on functional characterization of non-coding RNAs in cancer and development. |
 Charles Baudo, PhD
Charles Baudo, Ph.D. is a molecular biologist in the Genetic Sciences Division Clinical Vertical at Thermo Fisher Scientific, and his development efforts are focused on oncology applications. Recently, he was the lead developer on the Applied Biosystems™ TrueMark™ MSI Assay, a new MSI detection kit with an expanded marker set and automated analysis. Dr. Baudo previously worked at Genentech where he performed translational research to profile diagnostic biomarkers in gastric cancer. He earned his Doctorate in Cellular and Molecular Biology from Saint Louis University studying nuclear-mitochondrial interactions. |
 Yosuke Hirotsu, PhD
Dr. Hirotsu received Master's Degree of Medical Science in 2010 and completed Ph.D. of Medical Science in 2013 at The Tohoku University School of Medicine, Medical Biochemistry, Japan, where he studied the mechanism of transcriptional regulation for environmental stress, Keap1-Nrf2-sMaf system using molecular biology and mouse genetics. After graduation, he then continued to research the cancer genomics and clinical oncology at the Genome Analysis Center, Yamanashi Central Hospital, Japan. His research is focused on the genetic profiles, liquid biopsy and translational research using clinical specimens. |
 Michael Hummel, PhD
Prof. Dr Michael Hummel is head of the molecular diagnostics at the Institute of Pathology (Charité, Berlin) and a longstanding researcher with a scientific topic for molecular mechanisms in malignant lymphoma (more than 350 high ranking publications). Molecular diagnostics at Charité covers a broad spectrum of assays ranging from simple PCRs for the detection of viral and bacterial infections, complex PCRs for B- and T-cell clonality, RT-PCR based gene expression for breast cancer, FISH for chromosomal alterations and targeted NGS (started in June 2014) for mutation analysis in cancer tissues and liquid biopsies. The samples of many thousands of patients are being analyzed in our molecular lab every year. For the NGS assays, we are running the S5XL/ION Chef workflow as well as Illumina and QIAGEN platforms. Since March 2018, Charité is member of the Thermo Fisher Center of Excellence Program (COEP). In addition to the above described activities Michael Hummel is the director of the central biobank at the Charité and the Berlin Institute of Health (BIH). Furthermore he is Director of the German Biobank Node and Coordinator of the German Biobank Alliance. In this function he is responsible for the coordination and harmonization of the national biobanking activities and for the representation of the German biobank community at the European level in the frame of the biobanking infrastructure BBMRI-ERIC. |
 Sudha Murthy, MD
Dr Sudha S Murthy has over 20 years of experience as Chief of Pathology & Laboratory. Medicine at Basavatarakam Indo American Cancer Hospital & Research Institute, a premier tertiary care cancer hospital and advisor to many diagnostic labs trying to set up molecular assays and other cancer diagnostic testing. She brings to the table high end cancer diagnostic skills and liasoning skills with Oncologists. Her experience in healthcare management has helped her scale up diagnostic business with quality and lean processes addressed in this niche area of cancer. She is recognised for her efforts in raising the bar of oncopathology practice by envisioning and designing an integrated lab that comprises of basic histopathology, hematopathology to high end molecular lab with technologies like Next Generation Sequencing (NGS), RT PCR, FISH, 13 color flow cytometry etc. A passionate teacher, who has been awarded Teacher of Eminence in Pathology by the Association of NBE accredited institutes of Telangana and Andhra Pradesh in 2019, is known for grooming pathologists to excel in encouraging creative work environments. She has over 80 publications in peer reviewed national and international journals and several awards and honours to her credit. She is keen on leveraging the potential of NGS by bringing down the cost and making it accessible to cancer patients irrespective of their socioeconomic status and hopes to work with NGOs and policy makers to make this a reality. |
 Jon Sherlock, PhD
I completed my B.Sc. in Genetics at University College London (UCL) in 1993, before moving on to start a research career at Guys Hospital Medical School. I moved back to UCL where I completed my PhD. in pre-implantation and pre-natal research & diagnostics. I then held a post-doctoral research and lecturing post in the Obstetrics & Gynaecology Department at University College Hospital where I managed a team developing new diagnostic tests. After two sabbaticals setting up molecular diagnostic testing laboratories in Europe, I left academia to join my present company. After roles in Technical Support, Sales, Marketing and Business Development I now reside in California and run the oncology Product Management group in the Clinical Sequencing Division developing and managing diagnostic & research products including the first IVD labelled NGS kit for solid tumour testing as well as assays for immune oncology, cell-free, hemato-Oncology and paediatric cancer testing. As well as product development I also represent the organisation on scientific boards and collaborations. |
 Shantanu Kaushikkar, MS, MBA
Shantanu Kaushikkar is currently Director Product Marketing, Genotyping at Thermo Fisher Scientific. He part of the Microarray Leadership Team that is responsible for managing the microarray platform. Shantanu started his career in in medical imaging and held various positions at University of Washington in St. Louis, Missouri and Imatron Inc, California. Shantanu has been with Thermo Fisher Scientific for over 18 years in different positions in research and development and in product marketing. During this time he has led teams responsible for managing a diverse product portfolio including genotyping and gene expression microarrays, instruments, software and automation platforms for applications in human disease research and applied markets. He holds a master's degree in Biomedical Engineering from Case Western Reserve University, Cleveland Ohio, an M.B.A. from Santa Clara University, Santa Clara, California and a Bachelor of Science degree in Biomedical Engineering from Bombay University in India. |
 Kyung-Won Hong, PhD
Education 1) Bachelor's degree, Department of Biology, Pusan national univ. of Korea (1995-2002) 2) M.S, Department of Biology, Pusan national univ. of Korea (2002-2004) Graduation thesis : 'Molecular Feature and Evolution of Y chromosomal DNA in Primates' 3) Ph. D. Department of Applied biology, Gifu univ. of Japan (2004-2007) Graduation thesis : 'Effect of genetic polymorphisms on animal behavior' Brief History 1) 2015. 3. ~ present : Director (chief researcher), Div. of Healthcare innovation, Theragen 2) 2017. 9. ~ present : Adjunct Professor, Institute of digital anit-aging healthcare, Inje Univ. 3) 2013. 8 ~ 2015. 2 : Senior researcher, Department of Bioscience information, KCDC 4) 2011. 4 ~ 2013. 7 : Senior researcher, Department of Genome epidemiology, KCDC 5) 2010. 2 ~ 2011. 3 : Research professor, College of Medicine, Kyung Hee univ. 6) 2008. 7 ~ 2010. 1 : Chief researcher, Laboratory of Biomedical engineering, Kyung Hee univ. 7) 2007. 10 ~ 2008. 6 : Postdoctoral researcher, Department of Animal genomics, National institute of Animal Science Research Interest 1. Genome-Wide Association Study 2. Metagenome Study 3. Telomere Study 4. Methylation Study Research & Development projects 1) Develop personal genome testing service : Disease vulnerability analysis (Hellogene), Wellness beauty care (Genestyle) 2) Develop Bigdata analysis & Mobile app service (Genebanking) 3) Establish Bigdata analysis platform in Theragen Bio (Develop Theragen Precision Medicine Research Array) 4) Co-research : Amorepacific (Skin genome analysis), Dankook Univ. Hospital (Hair loss gene analysis), Ajou Univ. Hospital (Precocious puberty gene analysis) 5) Research Projects : Project of KCDC (Alcohol gene analysis), Project of National research foundation of Korea (Missing child identification gene analysis), Project of Ministry of trade, industry and energy (Jeju optimized cosmetic research), Project of Ministry of trade, industry and energy (Research of Bigdata healthcare based on wearable devise |
 Richard Pither, PhD
Richard Pither has been involved in the development of diagnostic and therapeutic pharmaceutical products for more than 25 years. He has been CEO at Cytox for the past 7 years, a precision medicine working on developing and commercialising a new diagnostic technology for assessing Alzheimer's Disease risk. Prior to Cytox, Richard has held senior R&D and leadership positions in global pharmaceutical companies including GE Healthcare/Amersham plc, Lorantis and UCB-Celltech. During this time, he was involved in the development of a novel 18F-PET radiopharmaceutical for imaging amyloid deposition in the brains of Alzheimer's disease patients. |